Gencor Industries (NYSE: GENC) faces NYSE American noncompliance after late Form 10‑Q
Rhea-AI Filing Summary
Gencor Industries, Inc. reported that it received a delinquency notification from NYSE Regulation because it did not file its Quarterly Report on Form 10‑Q for the period ended March 31, 2026 by the May 18, 2026 due date, including the Form 12b‑25 extension.
The company has six months from May 18, 2026 to regain compliance with NYSE American continued listing standards by filing the Form 10‑Q, and the exchange may, at its discretion, grant up to an additional six‑month extension or begin suspension and delisting proceedings at any time. Gencor says it currently expects to file within the initial six‑month period, but it cannot assure that this will occur, although the notice has no immediate effect on the listing or trading of its common stock.
Positive
- None.
Negative
- Gencor is noncompliant with NYSE American listing standards after failing to file its Form 10‑Q for the quarter ended March 31, 2026 by the May 18, 2026 deadline, creating a defined risk of potential suspension or delisting if the delay is not cured within the allowed timeframe.
Insights
Late 10‑Q filing triggers NYSE American noncompliance status for Gencor.
Gencor Industries disclosed it missed the Form 10‑Q deadline for the quarter ended March 31, 2026, even after using a Form 12b‑25 extension. NYSE Regulation issued a delinquency notification, formally placing the company out of compliance with NYSE American continued listing standards.
The company has six months from the May 18, 2026 due date to file the Form 10‑Q and regain compliance, with a possible discretionary six‑month extension under Section 1007 of the NYSE American Company Guide. The notification does not immediately affect trading, but NYSE may commence suspension or delisting at any time if circumstances warrant.
Management states it currently expects to file the Form 10‑Q within the initial six‑month window, while explicitly cautioning there is no assurance this will happen. The situation centers on regulatory and reporting timeliness rather than operating results, and its resolution will depend on whether Gencor completes and files the delayed report within the allowed timeframe.